Telecare Effective in Improving Pain Management
the Neurology Advisor take:
Telecare collaborative management can help primary-care patients better manage their chronic musculoskeletal pain, according to a study published in JAMA.Optimizing nonopioid analgesic medications using a stepped care algorithm and monitoring increased the proportion of patients with improved chronic musculoskeletal pain, Kurt Kroenke, MD, of the Indiana University School of Medicine in Indianapolis, and colleagues found.
The study included 250 patients with chronic musculoskeletal pain of at least moderate intensity (≥3 months, Brief Pain Inventory [BPI] score ≥5). The patients were enrolled from five primary care clinics in one Veterans Affairs medical center from June 2010 through May 2012. A 12-month follow-up was completed by June 2013.
Patients were randomly assigned to telephone-delivered collaborative care management intervention (n=124) or to usual care, where they received all pain care as usual from their primary care physicians (n=126). The intervention group received 12 months of telecare management that combined automated symptom monitoring with an algorithm-guided stepped-care approach to optimizing analgesics.
Mean baseline BPI scores in the intervention and control groups were 5.31 and 5.12, respectively. After 12 months, the intervention group had a 1.02-point lower BPI score compared with the usual care group. In the intervention group, 51.7% reported at least a 30% improvement in their pain score, compared with just 27.1% of the usual care group.
Telecare Effectively Improves Pain Management
The purpose of this study was to determine the effectiveness of a telecare intervention for chronic pain.
Kurt Kroenke, MD, of the Indiana University School of Medicine in Indianapolis, and colleagues found that telecare collaborative management increased the proportion of primary care patients with improved chronic musculoskeletal pain. This was accomplished by optimizing nonopioid analgesic medications using a stepped care algorithm and monitoring.
After 12 months, the intervention group had a 1.02-point lower BPI score compared with the usual care group. In the intervention group, 51.7% reported at least a 30% improvement in their pain score, compared with just 27.1% of the usual care group.
Next Article in Pain
Neurology Advisor Articles
- Efficacy of Cladribine Tablets in Patients With Relapsing Multiple Sclerosis
- Cognitive Performance, Mood Deficits, White Matter Hyperintensities in Migraine
- Disrupted Thalamo-Striato-Hypothalamic Function May Serve as a Good Biomarker for Parkinson Disease
- Rituximab Effectively Reduces Disease Activity in Multiple Sclerosis
- FDA to Review Sublingual Tx for Motor Fluctuations in Parkinson Disease
- Polyphenol-Rich Diet May Reduce Dementia Risk in Older Adults
- Addressing Migraine That Mimics Stroke
- Visual Association Test, MMSE Highly Predictive of Dementia in Older Adults
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Medical Cannabis Shows Promise in Treating Symptoms of Multiple Sclerosis
- Prevention of Recurrent Stroke Similar With Rivaroxaban, Aspirin
- Understanding ICU-Acquired Neuromuscular Dysfunction: Triggers, Risk Factors, and Treatments
- Cardiovascular Risks Persist Following Transient Ischemic Attack or Minor Stroke
- CVS Pharmacy Launches Prescription Delivery Service Nationwide
- Illicit Opioid Trade Up With Restrictions on Hydrocodone